Fennec Pharmaceuticals is trading at $10.75 (+5.91%) today, though no clear company-specific catalyst has been identified to explain the move.
- The price action appears to be driven by broader risk-on sentiment or sector-wide trends rather than a confirmed corporate announcement.
- There are no major earnings releases or regulatory updates matching the timing of the current jump.